Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dejka Araujo, MD
MD Anderson Cancer Center; Houston TX 77030
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Centre Leon Berard
Lyon, France
- Hospital Haut Leveque, Chu Bordeaux
Pessac, France
- Gustave Roussy Cancer Center
Villejuif, France
- Hospital Universitari Vall D'Hebron
Barcelona, Catalonia, Spain
- Start Madrid-Fjd, Fundación Jimѐnez Díaz
Madrid, Spain
- Hospital Universitario Virgen del Rocio
Seville, Spain
- Uclh Cancer Clinical Trials Unit
London, United Kingdom
- the Christie Nhs Foundation Trust
Manchester, United Kingdom
- City of Hope
Duarte, California, United States
- Stanford Cancer Center
Palo Alto, California, United States
- University of Colorado
Aurora, Colorado, United States
- Mayo Clinic Jacksonville
Jacksonville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Northwestern University Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- National Cancer Institute
Bethesda, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Ohio State University
Columbus, Ohio, United States
- Vanderbilt
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Fred Hutch
Seattle, Washington, United States
- Medical College of Wi Froedtert Hospital
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Aug 2019
- Primary completion
- 29 Aug 2021
- Completion
- 1 Apr 2038
- Last update posted
- 6 Feb 2026
- Registered enrollment
- 52
- Registry id
- NCT04044768
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.